+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Direct-to-Consumer Genetic Testing Market by Test Type, Technology, Business Model, Sales Channel - Global Forecast 2026-2032- Product Image
Direct-to-Consumer Genetic Testing Market by Test Type, Technology, Business Model, Sales Channel - Global Forecast 2026-2032- Product Image
Sale

Direct-to-Consumer Genetic Testing Market by Test Type, Technology, Business Model, Sales Channel - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968843
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Direct-to-Consumer Genetic Testing Market is projected to reach USD 3.25 Billion in 2026. It is expected to continue growing at a CAGR of 17.70%, reaching USD 8.73 Billion by 2032.

Direct-to-consumer genetic testing is moving from novelty ancestry discovery toward a broader consumer health, wellness, pharmacogenomics, and preventive-care ecosystem. The category is supported by verified scientific progress: the National Human Genome Research Institute has documented a steep decline in DNA sequencing costs since the Human Genome Project, while public resources such as ClinVar, gnomAD, and the GWAS Catalog continue to improve variant interpretation and evidence transparency.

Consumer demand is strongest where digital health adoption, e-commerce access, and genetic literacy intersect. Industry growth remains tied to trust: CLIA-certified laboratory processes in the United States, GDPR-aligned consent in Europe, and transparent data-use policies are increasingly central to brand differentiation in direct-to-consumer DNA testing, genetic ancestry testing, health risk screening, carrier testing, pharmacogenomics, and nutrition genomics.

Transformative Shifts in the Genetic Testing Landscape

The landscape is being reshaped by the convergence of lower sequencing costs, high-throughput genotyping, secure digital platforms, and consumer preference for personalized health insights. DTC genetic testing providers are expanding beyond ancestry into polygenic risk scores, pharmacogenetic markers, inherited condition screening, wellness traits, and family-planning applications, supported by advances in bioinformatics and digital report delivery.

Regulation is also transforming market behavior. FDA oversight of health-related genetic tests, FTC scrutiny of privacy and advertising claims, HIPAA limitations for non-covered consumer platforms, GDPR requirements in Europe, and country-specific rules on genetic data export are pushing providers toward more rigorous validation, clearer disclosures, stronger consent management, and improved post-test support.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the full DTC genetic testing value chain, from sample quality control and genotype imputation to variant classification, report generation, risk communication, and customer support. Machine learning models can help prioritize variants, detect population-specific signals, and connect genetic results with phenotype, lifestyle, and electronic health record data where legally permitted and ethically governed.

The cumulative impact is not only operational efficiency but also higher expectations for explainability, auditability, and bias control. Because genomic databases remain unevenly representative across ancestries, AI-driven genetic testing reports must disclose evidence strength, validation cohorts, clinical limitations, and uncertainty thresholds to avoid overstated health claims and inequitable risk prediction.

Key Regional Insights

North America leads adoption through mature e-commerce channels, consumer health awareness, CLIA laboratory infrastructure, genetic counseling access, and FDA-authorized pathways for selected health-related genetic reports. Europe is shaped by GDPR, national bioethics frameworks, and the EU In Vitro Diagnostic Regulation, which favor evidence-based claims, explicit consent, privacy-by-design business models, and stricter clinical performance documentation for health-related genetic testing.

Asia-Pacific is expanding as China, Japan, South Korea, India, Australia, and Singapore invest in genomics, precision medicine, and digital health infrastructure. Latin America is emerging through Brazil and Mexico, where private diagnostics networks, telehealth adoption, and urban consumer demand are growing. The Middle East, especially Gulf markets, is supported by national genome initiatives and high investment in preventive care, while Africa remains strategically important because global genomic datasets are still underrepresentative of African ancestry, creating both scientific need and long-term opportunity for more inclusive direct-to-consumer genetic testing.

Key Group Insights

The G7 remains central to commercialization because the United States, Canada, the United Kingdom, Germany, France, Italy, and Japan combine advanced laboratory systems, high purchasing power, established digital health usage, and active regulatory oversight. The European Union is especially influential through GDPR and IVDR, setting global expectations for consent, transparency, clinical evidence, post-market surveillance, and cross-border data governance in consumer genomics.

BRICS markets offer scale and genomic diversity, with China and India providing large populations and expanding genomics infrastructure, while Brazil, Russia, and South Africa contribute regional representation and underrepresented genomic data potential. ASEAN is gaining traction through Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, driven by digital health adoption, private healthcare expansion, and medical tourism. GCC markets are investing in national genome programs and preventive medicine, and NATO countries broadly align with data security, cyber resilience, trusted health technology, and protection of sensitive genetic information.

Key Country Insights

The United States remains the benchmark market for DTC genetic testing due to large consumer adoption, CLIA-certified laboratories, venture-backed digital health innovation, and FDA-authorized genetic health reports. Canada emphasizes privacy, consent, and responsible health communication, while Mexico and Brazil show rising demand through private diagnostics, telehealth, and urban middle-class health spending. The United Kingdom has strong genomic medicine infrastructure and public genomics expertise, while Germany, France, Italy, and Spain require careful alignment with national health, privacy, medical device, and laboratory rules.

China is scaling genomics through research capacity, sequencing infrastructure, and domestic digital health platforms, while India is gaining momentum through affordable diagnostics, preventive wellness demand, and expanding healthcare access. Japan and South Korea benefit from advanced healthcare systems, high technology adoption, and strong biomedical research capabilities. Australia supports consumer genetic testing through digital health engagement, research-grade genomics, and established laboratory standards, while Russia remains a complex market shaped by local data rules, scientific capacity, import constraints, and geopolitical considerations.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize analytical validity, clinical validity, and consumer comprehension across every product category. Health-related genetic reports should use clearly graded evidence, ancestry-aware risk models, transparent limitations, and access to clinicians or genetic counselors for results that may influence medical decisions, reproductive planning, medication selection, or preventive care.

Commercial teams should invest in privacy-first consent architecture, transparent data monetization policies, cybersecurity, lifecycle data governance, and localized regulatory strategies. Strategic partnerships with accredited laboratories, telehealth providers, healthcare systems, pharmaceutical researchers, and population genomics programs can improve scientific quality and operational scale while preserving trust in the direct-to-consumer genetic testing market.

Research Methodology

This executive summary is built from verified secondary research, regulatory analysis, and industry triangulation. Sources considered include public guidance and databases from the FDA, FTC, NIH, NHGRI, CDC, European Commission, national health authorities, peer-reviewed genomics literature, clinical variant repositories, laboratory quality standards, privacy regulations, and recognized data protection frameworks.

The methodology emphasizes data-backed interpretation rather than speculative claims. Market signals were evaluated across technology adoption, regulatory frameworks, laboratory infrastructure, consumer behavior, AI readiness, privacy requirements, genetic counseling access, public genomics initiatives, and regional genomics investment to identify sustainable growth drivers and risk factors.

Conclusion

Direct-to-consumer genetic testing is entering a more regulated, clinically connected, and AI-enabled phase. Growth potential will be strongest for providers that combine accessible consumer experiences with validated science, secure data governance, responsible interpretation of genetic risk, and inclusive datasets that better reflect global ancestry diversity.

As ancestry testing, health screening, pharmacogenomics, carrier testing, and wellness genomics converge, competitive advantage will shift from test volume alone to trust, evidence quality, regulatory readiness, transparency, and the ability to connect genetic insights with actionable and appropriately supported health decisions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Direct-to-Consumer Genetic Testing Market, by Test Type
7.1. Ancestry & Genealogy
7.2. Health Risk
7.3. Carrier Screening / Family Planning
7.4. Pharmacogenomics
7.5. Nutrigenomics
7.6. Comprehensive Genome Testing
8. Direct-to-Consumer Genetic Testing Market, by Technology
8.1. SNP Genotyping
8.2. Targeted NGS
8.3. Low-pass WGS
8.4. Whole Exome Sequencing
8.5. Whole Genome Sequencing
9. Direct-to-Consumer Genetic Testing Market, by Business Model
9.1. Usage-Based Sale
9.2. Freemium
9.3. Subscription/Membership
10. Direct-to-Consumer Genetic Testing Market, by Sales Channel
10.1. Direct Sales
10.2. Online Marketplace
10.3. Retail Pharmacy
11. Asia-Pacific Direct-to-Consumer Genetic Testing Market
12. North America Direct-to-Consumer Genetic Testing Market
13. Latin America Direct-to-Consumer Genetic Testing Market
14. Europe Direct-to-Consumer Genetic Testing Market
15. Middle East Direct-to-Consumer Genetic Testing Market
16. Africa Direct-to-Consumer Genetic Testing Market
17. ASEAN Direct-to-Consumer Genetic Testing Market
18. GCC Direct-to-Consumer Genetic Testing Market
19. European Union Direct-to-Consumer Genetic Testing Market
20. BRICS Direct-to-Consumer Genetic Testing Market
21. G7 Direct-to-Consumer Genetic Testing Market
22. NATO Direct-to-Consumer Genetic Testing Market
23. United States Direct-to-Consumer Genetic Testing Market
24. Canada Direct-to-Consumer Genetic Testing Market
25. Mexico Direct-to-Consumer Genetic Testing Market
26. Brazil Direct-to-Consumer Genetic Testing Market
27. United Kingdom Direct-to-Consumer Genetic Testing Market
28. Germany Direct-to-Consumer Genetic Testing Market
29. France Direct-to-Consumer Genetic Testing Market
30. Russia Direct-to-Consumer Genetic Testing Market
31. Italy Direct-to-Consumer Genetic Testing Market
32. Spain Direct-to-Consumer Genetic Testing Market
33. China Direct-to-Consumer Genetic Testing Market
34. India Direct-to-Consumer Genetic Testing Market
35. Japan Direct-to-Consumer Genetic Testing Market
36. Australia Direct-to-Consumer Genetic Testing Market
37. South Korea Direct-to-Consumer Genetic Testing Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. 23andMe Research Institute
39.2. 24Genetics S.L.
39.3. Ancestry.com LLC
39.4. Color Health, Inc.
39.5. CRI Genetics
39.6. Dante Labs International Inc.
39.7. DNA N U Ltd.
39.8. DNAfit
39.9. Gene by Gene, Ltd.
39.10. GenePlanet
39.11. Genoplan
39.12. Helix, Inc.
39.13. HomeDNA
39.14. Illumina Inc.
39.15. Laboratory Corporation of America Holdings
39.16. Living DNA Limited
39.17. Mapmygenome
39.18. MyHeritage Ltd.
39.19. Nebula Genomics
39.20. Prenetics Ltd.
39.21. tellmeGen
39.22. Veritas Intercontinental SL
39.23. WeGene
List of Figures
FIGURE 1. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANCESTRY & GENEALOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANCESTRY & GENEALOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANCESTRY & GENEALOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HEALTH RISK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HEALTH RISK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HEALTH RISK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CARRIER SCREENING / FAMILY PLANNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CARRIER SCREENING / FAMILY PLANNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CARRIER SCREENING / FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COMPREHENSIVE GENOME TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COMPREHENSIVE GENOME TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COMPREHENSIVE GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SNP GENOTYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SNP GENOTYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SNP GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TARGETED NGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TARGETED NGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TARGETED NGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL LOW-PASS WGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL LOW-PASS WGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL LOW-PASS WGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL USAGE-BASED SALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL USAGE-BASED SALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL USAGE-BASED SALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL FREEMIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL FREEMIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL FREEMIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SUBSCRIPTION/MEMBERSHIP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SUBSCRIPTION/MEMBERSHIP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SUBSCRIPTION/MEMBERSHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ONLINE MARKETPLACE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ONLINE MARKETPLACE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ONLINE MARKETPLACE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 65. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 67. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 78. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 80. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 81. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 82. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 85. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 90. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 91. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 92. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 93. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 95. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 96. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 97. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 100. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 101. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 102. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 105. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 107. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 110. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 111. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 112. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 115. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 117. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 120. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 122. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 124. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 125. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 127. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 129. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 130. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 132. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 134. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 135. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 137. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 139. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 140. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 142. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 144. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 145. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 147. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 150. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 152. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 154. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 155. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 157. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 159. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 160. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 162. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 163. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 165. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 167. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 169. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 170. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 172. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 174. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 175. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 177. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 179. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 180. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 182. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 184. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 185. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 187. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 189. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 190. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 191. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 192. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 195. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
TABLE 197. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Direct-to-Consumer Genetic Testing market report include:
  • 23andMe Research Institute
  • 24Genetics S.L.
  • Ancestry.com LLC
  • Color Health, Inc.
  • CRI Genetics
  • Dante Labs International Inc.
  • DNA N U Ltd.
  • DNAfit
  • Gene by Gene, Ltd.
  • GenePlanet
  • Genoplan
  • Helix, Inc.
  • HomeDNA
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Living DNA Limited
  • Mapmygenome
  • MyHeritage Ltd.
  • Nebula Genomics
  • Prenetics Ltd.
  • tellmeGen
  • Veritas Intercontinental SL
  • WeGene

Table Information

Report AttributeDetails
No. of Pages184
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.25 Billion
Forecasted Market Value ( USD ) by 2032 $ 8.73 Billion
Compound Annual Growth Rate17.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Direct-to-Consumer (DTC) Genetic Testing Market - Test Types, Technologies and Distribution Channels - Product Image

Direct-to-Consumer (DTC) Genetic Testing Market - Test Types, Technologies and Distribution Channels

  • Report
  • 262 Pages
  • Global
From
Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report - Product Image

Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report

  • Report
  • 267 Pages
  • Global
From
Direct-to-Consumer (DTC) Genetic Testing Market Report 2026 - Product Image

Direct-to-Consumer (DTC) Genetic Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Genetic Testing Market by Offering, Test Type, Technology, Sample Type, Application, End-User, Distribution Channel - Global Forecast 2026-2032 - Product Image

Genetic Testing Market by Offering, Test Type, Technology, Sample Type, Application, End-User, Distribution Channel - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Preimplantation Genetic Testing Market by Test Type, Technology Type, Offering, Procedure Stage, Application, End User - Global Forecast 2026-2032 - Product Image

Preimplantation Genetic Testing Market by Test Type, Technology Type, Offering, Procedure Stage, Application, End User - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From

About the Direct to Consumer Genetic Testing Market

Direct to Consumer Genetic Testing (DTCGT) is a type of genetic testing that allows individuals to access their genetic information without the need for a doctor or other healthcare provider. DTCGT companies provide genetic testing services directly to consumers, typically through a simple saliva sample. The results of the test can provide insight into an individual's ancestry, health risks, and other genetic traits. The DTCGT market has grown rapidly in recent years, driven by advances in genomics technology and the increasing availability of affordable testing services. Consumers are increasingly turning to DTCGT to gain access to their genetic information and to learn more about their health and ancestry. Some of the leading companies in the DTCGT market include 23andMe, AncestryDNA, Helix, and MyHeritage. These companies offer a range of services, from ancestry testing to health risk assessments. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.